Sal, Ertan ORCID: 0000-0003-2761-2675, Stemler, Jannik ORCID: 0000-0001-9152-2469, Salmanton-Garcia, Jon, Falces-Romero, Iker, Kredics, Laszlo, Meyer, Elisabeth, Wuerstl, Benjamin, Lass-Floerl, Cornelia, Racil, Zdenek, Klimko, Nikolay, Cesaro, Simone ORCID: 0000-0002-8698-9547, Kindo, Anupma Jyoti, Wisplinghoff, Hilmar, Koehler, Philipp, Cornely, Oliver A. ORCID: 0000-0001-9599-3137 and Seidel, Danila (2022). Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry. J. Antimicrob. Chemother., 77 (10). S. 2850 - 2859. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091

Full text not available from this repository.

Abstract

Background Trichoderma spp. are filamentous fungi causing invasive fungal diseases in patients with haematological malignancies and in peritoneal dialysis patients. Objectives To analyse clinical presentation, predisposing factors, treatment and outcome of Trichoderma infections. Methods A systematic literature review was conducted for published cases of invasive Trichoderma infection in PubMed until December 2021 and by reviewing the included studies' references. Cases from the FungiScope(R) registry were added to a combined analysis. Results We identified 50 invasive infections due to Trichoderma species, including 11 in the FungiScope(R) registry. The main underlying conditions were haematological malignancies in 19 and continuous ambulatory peritoneal dialysis (CAPD) in 10 cases. The most prevalent infection sites were lung (42%) and peritoneum (22%). Systemic antifungal therapy was administered in 42 cases (84%), mostly amphotericin B (n = 27, lipid-based formulation 13/27) and voriconazole in 15 cases (30%). Surgical interventions were performed in 13 cases (26%). Overall mortality was 48% (n = 24) and highest for allogeneic HSCT and solid organ transplantation (SOT) recipients [80% (4/5) and 77% (7/9), respectively]. In patients treated with amphotericin B, voriconazole and caspofungin, mortality was 55% (15/27), 46% (7/15) and 28% (2/7), respectively. Three out of four patients treated with a combination therapy of voriconazole and caspofungin survived. Conclusions Despite treatment with antifungal therapies and surgery, invasive Trichoderma infections are life-threatening complications in immunocompromised patients, especially after HSCT and SOT. In addition, Trichoderma spp. mainly affect the lungs in patients with haematological malignancies and the peritoneum in CAPD patients.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Sal, ErtanUNSPECIFIEDorcid.org/0000-0003-2761-2675UNSPECIFIED
Stemler, JannikUNSPECIFIEDorcid.org/0000-0001-9152-2469UNSPECIFIED
Salmanton-Garcia, JonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Falces-Romero, IkerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kredics, LaszloUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Meyer, ElisabethUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wuerstl, BenjaminUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lass-Floerl, CorneliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Racil, ZdenekUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klimko, NikolayUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cesaro, SimoneUNSPECIFIEDorcid.org/0000-0002-8698-9547UNSPECIFIED
Kindo, Anupma JyotiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wisplinghoff, HilmarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koehler, PhilippUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cornely, Oliver A.UNSPECIFIEDorcid.org/0000-0001-9599-3137UNSPECIFIED
Seidel, DanilaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-693610
DOI: 10.1093/jac/dkac235
Journal or Publication Title: J. Antimicrob. Chemother.
Volume: 77
Number: 10
Page Range: S. 2850 - 2859
Date: 2022
Publisher: OXFORD UNIV PRESS
Place of Publication: OXFORD
ISSN: 1460-2091
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
PATIENT; LONGIBRACHIATUM; PERITONITIS; ASPERGILLOSISMultiple languages
Infectious Diseases; Microbiology; Pharmacology & PharmacyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69361

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item